v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Assets [Abstract]    
Cash and cash equivalents $ 377,099 $ 119,639
Cash collateral posted to counterparties 244,440 118,225
Mortgage-backed securities (including pledged of $6,893,629 and $5,880,747, respectively), at fair value 7,512,087 6,038,948
Due from counterparties 10,445 1,313
Derivative assets 133 54,361
Accrued interest receivable 32,841 28,727
Other assets, net 7,534 8,537
Total assets 8,184,579 6,369,750
Liabilities:    
Repurchase agreements 6,563,120 5,381,104
Due to counterparties 341,924 95
Derivative liabilities 22,814 0
Cash collateral posted by counterparties 0 46,001
Accrued interest payable 44,672 53,194
Accrued dividends payable 16,501 10,320
Other liabilities 10,612 8,301
 Total liabilities 6,999,643 5,499,015
Preferred Stock, Liquidation Preference, Value 111,500 111,500
Stockholders' Equity Attributable to Parent [Abstract]    
Preferred stock, par value $0.01 per share; 50,000,000 shares authorized; 4,460,000 and 4,460,000 shares issued and outstanding, respectively ($111,500 and $111,500 aggregate liquidation preference, respectively) 107,843 107,843
Common stock, par value $0.01 per share, 180,000,000 shares authorized; 84,491,800 and 57,038,247 shares issued and outstanding, respectively 845 570
Additional paid-in capital 1,742,471 1,404,431
Accumulated other comprehensive loss (172,489) (158,502)
Accumulated deficit (493,734) (483,607)
 Total shareholders’ equity 1,184,936 870,735
Total liabilities and shareholders’ equity $ 8,184,579 $ 6,369,750

Source

10-K PDF XBRL Zip